2020 mAbTalk symposium

Revisit the Perspectives of Bispecific Antibodies under the COVID-19 Pandemic

Dec. 5, 2020, 8 a.m. US/Eastern

Zoom, Free for Everyone

Login to view recordings


Chinese Antibody Society invites you to join our 2020 mAbTalk virtual symposium, “Revisiting the Perspectives on Bispecific Antibodies under the COVID-19 Pandemic", on Dec 5th, 2020.

Bispecific and multispecific antibody-based therapies are at the cutting-edge of therapeutic biologics development, and provide new opportunities to address unmet medical needs. In our one-day symposium, eight speakers from both industry and academia will share insights on all aspects of bispecific antibody-based therapeutic development, including novel targets and molecular formats, development of the lead candidate from discovery to clinics, CMC challenges and strategies, regulatory considerations, patent protection strategies, and COVID-19 related therapeutics. Online LIVE Q & A sessions will be included after every presentation.

We sincerely hope you can join us online on December 5th (US EST) to enjoy the state-of-the-art science and direct communication with experts in the field.



title sponsor



Hover above speaker cards to read bio


Kedan Lin, PhD

VP, Innovent Biologics


Mitchell Ho, PhD

Sr. Investigator, LMB, NCI


Audrey Jia, MD, PhD

Principal Consultant, DataRevive


Ting Xu, PhD

Founder/CEO, Alphamab Oncology


Yue Liu, PhD

Founder/CEO, Ab Studio and Ab Therapeutics


Paul Parren, PhD

Executive VP, Lava Therapeutics


Teresa Lavoie, PhD

Principal, Fish & Richardson


Jizu Yi, PhD

SVP, YZY Biopharma


David Ho, MD

Director, AIDS Center, Columbia Univ.


Jijie Gu, PhD

CSO/EVP, WuXi Biologics


Starts at 12/05/2020 8 a.m. US/Eastern

Hover to view abstract

12/05/2020 8 a.m. US/Eastern

Chairperson's Remarks

Mitchell Ho, PhD, Sr. Investigator, LMB, NCI

12/05/2020 8:05 a.m. US/Eastern

Next Wave of Innovation of Drug Discovery Driven by Antibody-based Multispecific and Functional Drugs

Jijie Gu, PhD, CSO/EVP, WuXi Biologics

12/05/2020 8:45 a.m. US/Eastern

Development of KN046 - a PD-L1/CTLA-4 BsAb

Ting Xu, PhD, Founder/CEO, Alphamab Oncology

12/05/2020 9:15 a.m. US/Eastern

CMC Challenges and Strategies for Bispecific Antibody Development

Jizu Yi, PhD, SVP, YZY Biopharma

12/05/2020 9:45 a.m. US/Eastern

Bispecific γδ-T cell Engagers for Cancer Immunotherapy.

Paul Parren, PhD, Executive VP, Lava Therapeutics

12/05/2020 10:15 a.m. US/Eastern

Potent Neutralizing Monoclonal Antibodies Directed to Multiple Epitopes on the SARS-CoV-2 Spike.

David Ho, MD, Director, AIDS Center, Columbia Univ.

12/05/2020 10:45 a.m. US/Eastern

Regulatory Challenges and opportunities for biological products

Audrey Jia, MD, PhD, Principal Consultant, DataRevive

12/05/2020 11:15 a.m. US/Eastern


CAS Staff, , The Chinese Antibody Society

12/05/2020 12:45 p.m. US/Eastern

Patent Protection Strategies for Bispecific Antibodies

Teresa Lavoie, PhD, Principal, Fish & Richardson

12/05/2020 1:15 p.m. US/Eastern

Combining Computer Aided Design and Traditional Antibody Discovery and Engineering Technologies to Develop Multi-Specific Antibodies

Yue Liu, PhD, Founder/CEO, Ab Studio and Ab Therapeutics

FAQ of Meeting Registration

If you have any questions, feel free to reach out to us
Yes! It's free for both CAS members and non-members
Follow these simple steps to register and connect:
1. Click on the registration button at the top of the page, then answer a few simple questions to register
2. You will a receive a invitation link in the email that you can use to connect to the event
3. Before the event starts, download the Goto Webinar app (Mac, Windows, mobile phone compatible) here
4. Click on the invitation link in your email to join the meeting
Yes! GotoWebinar is available for users outside of U.S., including China and Europe
We will be hosting a WeChat group for all attendees.
If you have joined our the WeChat group for attendees, the easiest way to get a response is to post your question there. Otherwise, send us an email at conference@chineseantibody.org